Author

A. F. Gad

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:variant calling· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

B. E. Harty· 2 shared M. F. Mohamed· 2 shared M. G. Seadawy· 2 shared M. S. ELdesoky· 2 shared A. A. Elfiky· 1 shared A. Ahmed· 1 shared A. N. Zekri· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. E. Harty

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

in vitro: Natural Compounds (Thymol, Carvacrol, Hesperidine, And Thymoquinone) Against SARS-CoV2 Strain Isolated From Egyptian Patients

M. G. Seadawy, A. F. Gad, B. E. Harty, M. F. Mohamed, M. S. ELdesoky, A. A. Elfiky, A. Ahmed, A. N. Zekri

The paper tests natural compounds against SARS-CoV-2 using molecular docking, cytotoxicity, and plaque reduction assays, showing potential binding to viral targets.

bioRxiv · Nov 7, 2020Microbiology

Identification, Isolation, Propagation And Inactivation Of SARS-CoV2 Isolated From Egypt

M. G. Seadawy, A. F. Gad, B. E. Harty, M. S. Eldesoky, M. F. Mohamed

This study isolates, propagates, and inactivates SARS-CoV-2 from Egyptian patients to develop an inactivated vaccine production methodology.

bioRxiv · Nov 4, 2020 · PreprintMicrobiology